[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100480431":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":19,"centralContacts":10,"locations":23,"responsibleParty":37,"collaborators":10,"id":39,"slug":40,"hasResults":41,"nctId":42,"briefTitle":43,"officialTitle":44,"acronym":10,"eligibilityCriteria":45,"healthyVolunteers":41,"sex":46,"minAge":47,"maxAge":10,"enrollmentInfo":48,"targetDuration":10,"studyType":51,"phases":10,"briefSummary":52,"conditions":53,"keywords":10,"overallStatus":55,"whyStopped":10,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":64},{"fullName":5,"class":6},"West Virginia University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Unresectable Pancreatic Cancer",null,"Endoscopic Ultrasound-guided Radiofrequency Ablation of Celiac Ganglion",[13],"Procedure: Ablation of Celiac Ganglion",[15],{"type":16,"name":17,"description":11,"armGroupLabels":18,"otherNames":10},"PROCEDURE","Ablation of Celiac Ganglion",[9],[20],{"name":21,"affiliation":5,"role":22},"Shailendra Singh, MD","PRINCIPAL_INVESTIGATOR",[24],{"facility":25,"status":10,"city":26,"state":27,"zip":28,"country":29,"countryCode":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":10},"Shailendra Singh","Morgantown","West Virginia","26508","United States","US",{"type":32,"coordinates":33},"Point",[34,35],-79.9559,39.62953,{"lat":35,"lon":34},{"type":22,"investigatorFullName":25,"investigatorTitle":38,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Associate Professor & Director, Bariatric Endoscopy","100480431","endoscopic-radiofrequency-ablation-of-celiac-ganglion-for-pain-management-and-improvement-of-quality-of-life-in-patients-with-unresectable-pancreatic-cancer-100480431",false,"NCT05535894","Endoscopic Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer","Endoscopic Ultrasound-guided Radiofrequency Ablation of Celiac Ganglion for Pain Management and Improvement of Quality of Life in Patients With Unresectable Pancreatic Cancer","Inclusion Criteria:\n\n* Diagnosis of pancreatic cancer based on clinical, radiological, or pathological assessment;\n* Referred for abdominal and\u002For back pain due to pancreatic cancer;\n* No prior history of RFA;\n* Cancer pain unresponsive to the WHO 3-step analgesic ladder;\n* Willingness to consent to participate in the study.\n\nExclusion Criteria:\n\n* Patients who are not willing to give informed consent or agree to participate in the study\n* Surgically resectable pancreatic cancer;\n* Abdominal pain with etiology other than pancreatic malignancy;\n* Evidence of concurrent infection;\n* Patients with irreversible coagulopathy international normalized ratio \\>1.5 or platelet count \\\u003C50,000\u002Fmm3),\n* Patients with a preliminary diagnosis of adenocarcinoma are not possible established with intraprocedural at EUS-guided FNA.","ALL","18 Years",{"count":49,"type":50},19,"ACTUAL","OBSERVATIONAL","This study aims to evaluate the EUS-RFA in terms of efficacy for pain management and improvement in quality-of-life parameters for patients with advanced inoperable pancreatic cancer. The primary objectives of this study are to 1) evaluate the utility of EUS-RFA for pain control and improvement in quality-of-life parameters for patients with advanced pancreatic cancer; 2) to measure the reduction of analgesic medications' requirements in patients affected by inoperable pancreatic cancer.",[54],"Pancreatic Cancer","COMPLETED","2026-04-23",{"date":58,"type":50},"2026-04-28",{"date":60,"type":50},"2022-08-10",{"date":62,"type":50},"2025-08-30",{"name":5,"class":6},1]